News

Trident Lifeline Limited announced a preferential allotment of equity shares and warrants to 33 investors, including promoters, promoter group members, and non-promoter entities, in a move to raise capital. The company’s board approved the allotment on October 5, 2026, with an issue price of Rs 336.60 per share and warrant. The allotment will result in a dilution for existing shareholders, with the promoters’ shareholding decreasing from 62.46% to 56.35% and the public shareholding increasing from 37.54% to 43.65% assuming full warrant exercise. Each warrant is convertible into one equity share, requiring a 25% upfront payment with the remaining 75% due upon exercise. A detailed list of investors and the securities offered to each is included in an annexure to the filing.

Trident Lifeline Limited announced a preferential allotment of 1,42,16,000 equity shares and 5,36,400 warrants to 33 investors, including promoters, promoter groups, and public shareholders, at an issue price of Rs 336.60 per share/warrant. The move, based on a valuation report dated October 5, 2026, from Registered Valuer Anurag Singal, will increase shareholding for both promoters and public investors. Warrants will be convertible into equity shares, with 25% of the price payable upfront and the remaining 75% upon exercise. The allotment is expected to adjust the shareholding pattern, decreasing the promoter and promoter group share from 62.46% to 56.35% and increasing the public share from 37.54% to 43.65%.

Trident Lifeline Limited has increased its stake in Trident Mediquip Limited, a subsidiary company, by acquiring an additional 1.00% equity stake, bringing its total shareholding to 59.67% from 58.67%. The acquisition, undertaken on an arm’s length basis, involved a cash consideration of approximately Rs 95.40 crore. Trident Mediquip Limited, incorporated in October 2019, operates in the medical device industry and reported a turnover of Rs 27.31 crore for the financial year 2025-26.

Trident Lifeline Limited informed the BSE Limited that the trading window for dealing in securities of the company will remain closed from September 29, 2026, and will re-open 48 hours from the conclusion of the Board of Directors meeting to be held for considering the unaudited financial results for the quarter and half year ended September 30, 2026.

Trident Lifeline Limited will seek to raise funds through the potential issue of warrants, equity shares, or convertible securities, according to a regulatory filing with the BSE Limited on September 29, 2026; the company’s board of directors will convene on October 5, 2026, to discuss the proposal and appoint necessary intermediaries. Trading window for the company`s securities will be closed from September 29, 2026, and will reopen on October 7, 2026.